Evidence map›Paper›PMID 30926581›Full record

ArticleCellular and molecular gastroenterology and hepatology2019

Hepatic Lysosomal iNOS Activity Impairs Autophagy in Obesity.

Qingwen Qian, Zeyuan Zhang, Mark Li, Kalie Savage, Dechun Cheng, Adam J Rauckhorst, James A Ankrum, Eric B Taylor, Wen-Xing Ding, Yi Xiao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 35 citations in OpenAlex.

  1. HIV-1 gp120-induced lysosomal stress responses are controlled by TRPML1 redox sensors.Redox report : communications in free radical research · 2026
    Article
  2. Contradictory Effects on Hepatocytes in ASMD.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Autophagy in liver diseases.World journal of hepatology · 2021
    Review
  17. Autophagy in Hepatic Steatosis: A Structured Review.Frontiers in cell and developmental biology · 2021
    Review
  18. Review
  19. Review
  20. NO to Lysosomes: A Signal for Insulin Resistance in Obesity.Cellular and molecular gastroenterology and hepatology · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Qingwen QianDepartment of Anatomy and Cell Biology, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Zeyuan ZhangDepartment of Anatomy and Cell Biology, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Mark LiDepartment of Anatomy and Cell Biology, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Kalie SavageDepartment of Anatomy and Cell Biology, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Dechun ChengDepartment of Parasitology, Harbin Medical School, Harbin, China.
Adam J RauckhorstDepartment of Biochemistry, Fraternal Order of Eagles Diabetes Research Center, Fraternal Order of Eagles Diabetes Research Center Metabolomics Core, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa.
James A AnkrumRoy J. Carver Department of Biomedical Engineering, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa College of Engineering, Iowa City, Iowa.
Eric B TaylorDepartment of Biochemistry, Fraternal Order of Eagles Diabetes Research Center, Fraternal Order of Eagles Diabetes Research Center Metabolomics Core, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Wen-Xing DingDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas.
Yi XiaoState Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, China.
Huo-Jun CaoDepartments of Endodontics, University of Iowa College of Dentistry, Iowa City, Iowa.
Ling YangDepartment of Anatomy and Cell Biology, Fraternal Order of Eagles Diabetes Research Center, Pappajohn Biomedical Institute, University of Iowa Carver College of Medicine, Iowa City, Iowa. Electronic address: ling-yang@uiowa.edu.
University of Iowa · USDalian University of Technology · CNHarbin Medical University · CNUniversity of Kansas Medical Center · US

Funding

Nuclear Receptors in Liver Health and DiseaseP20GM103549 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2012 to 2015
$8.1M
Pilot Grants ProgramP30GM118247 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2016 to 2020
$5.5M
Regulation of Hepatic Macronutrient Metabolism by Mitochondrial Citrate TransportR01DK104998 · NIDDK · UNIVERSITY OF IOWA · PI TAYLOR, ERIC B · 2015 to 2022
$3.2M
Autophagy and Drug-Induced Liver InjuryR01DK102142 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING, JAESCHKE, HARTMUT W. · 2014 to 2022
$2.7M
Mechanisms regulating autophagy in alcohol-induced liver injuryR01AA020518 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2011 to 2018
$2.3M
Integration of Inflammatory Signaling and the Unfolded Protein Response by Nitrosylation Signaling in ObesityR01DK108835 · NIDDK · UNIVERSITY OF IOWA · PI YANG, LING · 2018 to 2022
$1.9M
Autophagy in Alcoholic PancreatitisU01AA024733 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2017 to 2021
$1.7M
NIAAA NIH HHS R01 AA020518NIAAA NIH HHS U01 AA024733NIDDK NIH HHS R01 DK102142NIDDK NIH HHS R01 DK104998NIDDK NIH HHS R01 DK108835NIGMS NIH HHS P20 GM103549NIGMS NIH HHS P30 GM118247
6 · The paper itself

Abstract

BACKGROUND &

aimsThe lysosome is an acidic organelle that is important for maintaining cellular and metabolic homeostasis in hepatocytes. Lysosomal dysfunction and chronic inflammation coexist, and both contribute to obesity-associated hepatic insulin resistance. However, in the context of obesity, the interplay between inflammatory signals and hepatic lysosomal function remains largely unknown. Inducible nitric oxide synthase (iNOS) is a hallmark for inflammation, and is activated in obesity. The aim of this study is to understand the molecular link between iNOS-mediated lysosomal nitric oxide (NO) production, hepatic lysosomal function, and autophagy in the context of obesity-associated insulin resistance.

methodsThe role of iNOS in hepatic autophagy, as related to insulin and glucose homeostasis were studied in mice with diet-induced obesity (DIO). The effects and mechanisms of iNOS-mediated lysosomal NO production on lysosomal function and hepatic autophagy were studied in primary hepatocytes as well as in a mouse model of DIO.

resultsWe demonstrate that obesity promotes iNOS localization to the lysosome and decreases levels of lysosomal arginine, resulting in an accumulation of NO in hepatic lysosomes. This lysosomal NO production is attenuated by treatment with a NO scavenger, while co-overexpression of mTOR and a lysosomal arginine transporter (SLC38A9) enhances lysosomal NO production and suppresses autophagy. In addition, we show that deletion of iNOS ameliorates lysosomal nitrosative stress in the livers of DIO mice, promotes lysosomal biogenesis by activating transcription factor EB (TFEB), and enhances lysosomal function and autophagy. Lastly, deletion of iNOS in mice with DIO improves hepatic insulin sensitivity, which is diminished by suppression of TFEB or autophagy related 7 (Atg7).

conclusionsOur studies suggest that lysosomal iNOS-mediated NO signaling disrupts hepatic lysosomal function, contributing to obesity-associated defective hepatic autophagy and insulin resistance.

Indexed as

AnimalsArginineAutophagyCells, CulturedDiet, High-FatDisease Models, AnimalHepatocytesInsulin ResistanceLiverLysosomesMaleMiceNitric OxideNitric Oxide Synthase Type IINitrosative StressObesityArginineNitric OxideNitric Oxide Synthase Type IINos2 protein, mouseAutophagyInducible Nitric Oxide SynthaseInsulin ResistanceLysosomeNitric Oxide

Identifiers

PMID30926581
PMCPMC6522853
OpenAlexW2923601548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.